Fundraising FoxMitsui & Co — 2023 Investments
3 investments dated 2023 · listed companies and verified rows first · show all
Quantinuum develops quantum computers and quantum software solutions for applications in drug discovery, healthcare, materials science, cybersecurity, and energy.
Deep TechEnterprise SoftwareQuantum ComputingBroomfield, US
Ilyas Khan(Founder)inRajeeb Hazra(Founder)inAvinash Palaniswamy(Chief Commercial Officer)Susan Schwamberger(Chief Human Resources Officer and SVP Operations)inJennifer Strabley(VP and General Manager, Compute Products)inWaseem Shiraz(Senior VP Strategic Initiatives & Chief of Staff)in
Co-investorsAccess Ventures (New York)Adequita CapitalEdenBaseHoneywell VenturesICON Quantum VenturesKhosla Ventures+14 more
Koios Medical develops FDA-cleared, CE-marked AI software that assists physicians in diagnosing breast and thyroid cancer from ultrasound images.
AI & Machine LearningBiotechDigital HealthMedical DevicesNew York, US
Robert Chad McClennan(Executive Officer, Promoter)GRAHAM ANDERSON(Executive Officer, Promoter)in
BoardCHRISTINE LI(Director)GREGORY MORAN(Director)MARK GLASGOLD(Director)
Mirxes develops RNA-based molecular diagnostics for early cancer detection, treatment selection, and multiomics research.
BiotechHealthtechMedical Devices
Co-investorsXeraya CapitalEDB Investments
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.